122 related articles for article (PubMed ID: 26566312)
1. Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.
Sujishi T; Fukunishi S; Ii M; Nakamura K; Yokohama K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
J Clin Biochem Nutr; 2015 Nov; 57(3):244-53. PubMed ID: 26566312
[TBL] [Abstract][Full Text] [Related]
2. A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.
Nakamura K; Fukunishi S; Yokohama K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2017 Apr; 39(4):969-983. PubMed ID: 28260070
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
4. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
Li H; Ying H; Hu A; Hu Y; Li D
Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
[TBL] [Abstract][Full Text] [Related]
8. Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.
Kim CW; Addy C; Kusunoki J; Anderson NN; Deja S; Fu X; Burgess SC; Li C; Ruddy M; Chakravarthy M; Previs S; Milstein S; Fitzgerald K; Kelley DE; Horton JD
Cell Metab; 2017 Aug; 26(2):394-406.e6. PubMed ID: 28768177
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice.
Yang Y; Li J; Wei C; He Y; Cao Y; Zhang Y; Sun W; Qiao B; He J
Phytomedicine; 2019 Jun; 59():152782. PubMed ID: 31005808
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of preventive effects of exendin-4 and des-fluoro-sitagliptin in a murine model of fructose-induced prediabetes.
Castro MC; Villagarcía HG; Schinella G; Massa ML; Francini F
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159363. PubMed ID: 37429413
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice.
Onoyama T; Koda M; Okamoto T; Kishina M; Matono T; Sugihara T; Murawaki Y
Mol Med Rep; 2015 Nov; 12(5):6895-902. PubMed ID: 26397061
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
[TBL] [Abstract][Full Text] [Related]
13. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice.
Zheng W; Zhou J; Song S; Kong W; Xia W; Chen L; Zeng T
Int J Endocrinol; 2018; 2018():8309723. PubMed ID: 30123267
[TBL] [Abstract][Full Text] [Related]
15. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice.
Zhang C; Chen X; Zhu RM; Zhang Y; Yu T; Wang H; Zhao H; Zhao M; Ji YL; Chen YH; Meng XH; Wei W; Xu DX
Toxicol Lett; 2012 Aug; 212(3):229-40. PubMed ID: 22698815
[TBL] [Abstract][Full Text] [Related]
17. High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.
Wooten JS; Nick TN; Seija A; Poole KE; Stout KB
J Clin Exp Hepatol; 2016 Dec; 6(4):265-274. PubMed ID: 28003715
[TBL] [Abstract][Full Text] [Related]
18. RETRACTED: Reversion of hepatic steatosis by exercise training in obese mice: the role of sterol regulatory element-binding protein-1c.
Cintra DE; Ropelle ER; Vitto MF; Luciano TF; Souza DR; Engelmann J; Marques SO; Lira FS; de Pinho RA; Pauli JR; De Souza CT
Life Sci; 2012 Oct; 91(11-12):395-401. PubMed ID: 22906631
[TBL] [Abstract][Full Text] [Related]
19. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
20. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
